|
U.S. Covid vaccinations — including boosters — fall to lowest levels since 2020 |
mike kraft |
Group Post |
03/25/22 |
|
U.S. Covid winters are making long hospital waits the new normal |
mike kraft |
Group Post |
01/18/23 |
|
U.S. Covid, flu, RSV cases declining in hospitals as ‘tripledemic’ threat fades |
mike kraft |
Group Post |
01/23/23 |
|
U.S. COVID, RSV activity still high but continues ebb post holidays |
mike kraft |
Group Post |
01/29/24 |
|
U.S. Covid-19 booster shot uptake is at all-time low, CNN analysis |
mike kraft |
Group Post |
02/15/22 |
|
U.S. Covid-19 cases are starting to rise amid flu and RSV outbreaks |
mike kraft |
Group Post |
12/16/22 |
|
U.S. Covid-19 cases in children are up 32% from two weeks ago -- pediatricians' group |
mike kraft |
Group Post |
11/23/21 |
|
U.S. COVID-19 deaths drop for first time in four weeks--Reuters |
mike kraft |
Group Post |
08/10/20 |
|
U.S. COVID-19 hospitalizations hit record low - CDC |
mike kraft |
Group Post |
04/30/24 |
|
U.S. COVID-19 patients in rural areas have higher death rates following hospital stays --study |
mike kraft |
Group Post |
04/08/24 |
|
U.S. COVID-19 vaccine requirements for federal workers, int'l travelers to end May 11 |
mike kraft |
Group Post |
05/03/23 |
|
U.S. crosses 500,000th COVID-19 death |
mike kraft |
Group Post |
02/22/21 |
|
U.S. cut climate pollution in 2023, but not fast enough to limit global warming |
mike kraft |
Group Post |
01/10/24 |
|
U.S. daily COVID cases drop to below 10,000 --vaccinations credited |
mike kraft |
Group Post |
06/04/21 |
|
U.S. dairy products, ground beef tested negative for bird flu--US Agriculture Department |
mike kraft |
Group Post |
05/02/24 |
|
U.S. Debt limit deal claws back unspent COVID relief money for various agencies including CDC |
mike kraft |
Group Post |
05/31/23 |
|
U.S. detects first case of COVID-19 variant as Biden offers gloomy vaccine outlook |
mike kraft |
Group Post |
12/29/20 |
|
U.S. doctors find themselves navigating political landmines as conservative views criticize recommendations, science |
mike kraft |
Group Post |
10/04/23 |
|
U.S. Doctors seek more information on Paxlovid prescribing amid Covid-19 rebound concerns |
mike kraft |
Group Post |
07/07/22 |
|
U.S. dropped from list of COVID-safe countries for travel to Europe |
mike kraft |
Group Post |
08/30/21 |
|
U.S. East Coast cities from NYC to DC and south are sinking--new studies |
mike kraft |
Group Post |
01/03/24 |
|
U.S. emerges as outlier on Covid measures as Biden faces political headwinds |
mike kraft |
Group Post |
12/02/21 |
|
U.S. exceeds 400,000 coronavirus deaths |
mike kraft |
Group Post |
01/19/21 |
|
U.S. expanding airport nasal swabbing to Chicago and Miami |
mike kraft |
Group Post |
03/13/24 |
|
U.S. expected to advise COVID booster shots for most Americans at 8 months |
mike kraft |
Group Post |
08/17/21 |
|
U.S. expected to provide additional 500 million Pfizer-BioNTech doses to 100 nations over the next year |
mike kraft |
Group Post |
06/09/21 |
|
U.S. Experts expect subvariants to cause ‘substantial’ summer cases of COVID-19 |
mike kraft |
Group Post |
06/27/22 |
|
U.S. extends COVID vaccine requirements for non-citizens at land borders |
mike kraft |
Group Post |
04/21/22 |
|
U.S. extends public health emergency status for COVID |
mike kraft |
Group Post |
01/11/23 |
|
U.S. F.D.A. advisers recommend updated boosters that target Omicron variants |
mike kraft |
Group Post |
06/28/22 |
|
U.S. faces a double coronavirus surge as omicron advances |
mike kraft |
Group Post |
12/16/21 |
|
U.S. FDA cleares the first home flu and Covid test — but its maker just declared bankruptcy |
mike kraft |
Group Post |
02/27/23 |
|
U.S. FDA advisers recommend Pfizer/BioNTech COVID-19 vaccine for children |
mike kraft |
Group Post |
10/26/21 |
|
U.S. FDA aims to decide on strain selection for COVID boosters by June |
mike kraft |
Group Post |
04/07/22 |
|
U.S. FDA approves antibody to protect infants from RSV |
mike kraft |
Group Post |
07/18/23 |
|
U.S. FDA approves COVID preventive Pemgarda for immunocompromised persons |
mike kraft |
Group Post |
03/26/24 |
|
U.S. FDA approves first RSV vaccine, a long-sought scientific achievement |
mike kraft |
Group Post |
05/03/23 |
|
U.S. FDA approves Gilead's COVID-19 drug for young children |
mike kraft |
Group Post |
04/25/22 |
|
U.S. FDA approves RSV monoclonal antibody for infants, young children at high risk |
mike kraft |
Group Post |
07/18/23 |
|
U.S. FDA authorization for updated Covid-19 boosters for younger ages could come as soon as early October |
mike kraft |
Group Post |
09/29/22 |
|
U.S. FDA authorizes first COVID-19 shot for young kids |
mike kraft |
Group Post |
10/29/21 |
|
U.S. FDA authorizes Moderna's COVID-19 vaccine for emergency use |
mike kraft |
Group Post |
12/18/20 |
|
U.S. FDA authorizes Moderna, Pfizer updated COVID boosters for 6 months old |
mike kraft |
Group Post |
12/08/22 |
|
U.S. FDA authorizes Novavax's COVID vaccine as booster for adults |
mike kraft |
Group Post |
10/19/22 |
|
U.S. FDA authorizes Pfizer/BioNTech booster for 16- and 17-year-olds |
mike kraft |
Group Post |
12/09/21 |
|
U.S. FDA authorizes spring covid booster shots for older adults and the immunocompromised |
mike kraft |
Group Post |
04/18/23 |
|
U.S. FDA authorizes use of AstraZeneca COVID-19 antibody cocktail |
mike kraft |
Group Post |
12/08/21 |
|
U.S. FDA clears updated COVID boosters for kids as young as 5 |
mike kraft |
Group Post |
10/12/22 |
|
U.S. FDA cuts gap for Moderna COVID-19 booster dose to 5 months |
mike kraft |
Group Post |
01/07/22 |
|
U.S. FDA gearing up for rapid review of potential COVID-19 booster shots |
mike kraft |
Group Post |
02/05/21 |
Recent Comments